Join to View Full Profile
330 Brookline AvenueBoston, MA 02215
Phone+1 617-667-9236
Dr. Costa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Yale-New Haven Medical Center (Primary Care)Residency, Internal Medicine, 2001 - 2004
Univ Sao Paulo- Fac MedClass of 2000
Certifications & Licensure
MA State Medical License 2004 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer Start of enrollment: 2019 Jun 06
Roles: Principal Investigator, Contact
- Osimertinib In EGFR Mutant Lung Cancer Start of enrollment: 2018 Aug 13
Roles: Contact
- Lorlatinib Combinations in Lung Cancer Start of enrollment: 2020 May 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Patterns of HER2 expression and genomic correlates in lung cancer, with a focus on preanalytical variables impacting immunohistochemical staining results.Cristiana M Pineda, Lauren O'Loughlin, Heather L Benjamin, Deepa Rangachari, Hollis Viray
Journal of Clinical Pathology. 2025-03-12 - Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC...Yuji Uehara, Hiroki Izumi, Ikei S Kobayashi, Shingo Matsumoto, Yukio Hosomi
Lung Cancer. 2025-03-05 - How to select between osimertinib or afatinib in P-loop and αC-helix compressing (G719X, S768I) or classical-like (L861Q) EGFR mutations: what preclinical models and c...Julia M Berg, Toshiki A Kobayashi, Daniel B Costa
Translational Cancer Research. 2025-01-31
Press Mentions
2 Canadian Healthcare Stocks That Are All-Stars in the MakingSeptember 29th, 2021- 2 Canadian Stocks to Buy That Could Double in 12 MonthsJune 25th, 2021
- 3 Top Canadian Growth Stocks to Buy Before They Take OffJune 24th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
